VGX is an award show hosted by Spike TV that recognizes the best computer and video games of the year. Beginning in 2003, the Spike TV Video Game Awards garnered much attention, since video game awards were not common prior to its introduction. The VGAs feature live music performances and appearances by popular performers in music, movies, and television. Additionally, preview trailers for upcoming games are highlighted.
2013 Video Game Awards
Episode 11x1; Dec 07, 2013
11x1: 2013 Video Game Awards
10x1: 2012 Video Game Awards
9x1: 2011 Video Game Awards
8x1: 2010 Video Game Awards
7x1: 2009 Video Game Awards
6x1: 2008 Video Game Awards
5x1: 2007 Video Game Awards
4x1: 2006 Video Game Awards
3x1: 2005 Video Game Awards
CastView Full Cast
Recent Newsvia NewsAPI
View More Related News
Inovio Pharmaceuticals Reports Positive Trail Data for Cancer Vaccine
The results from its study of VGX-3100 are an encouraging signal that the biotech's coronavirus vaccine might work too.
Inovio Pharmaceuticals (NASDAQ:INO), which has become famous for the exceptionally rapid development of its candidate COVID-19 vaccine, reported data for its lead vaccine candidate, VGX-3100, which treats anal dysplasia, a precancerous condition caused by hum… [+2095 chars]
Why Inovio Pharmaceuticals Stock Soared Today
Investors like the biotech's good news from a phase 2 clinical trial.
What happened Shares of Inovio Pharmaceuticals(NASDAQ:INO) were soaring 13.4% higher as of 3:10 p.m. EDT on Friday. The big jump came after Inovio reported positive interim results on Thursday from a phase 2 clinical study evaluating experimental drug VGX-31… [+1481 chars]
Should You Buy Inovio Pharmaceuticals During the Coronavirus Market Crash?
The small biotech has a promising pipeline that includes a potential COVID-19 vaccine. But is that enough to justify buying Inovio stock?
Inovio Pharmaceuticals(NASDAQ:INO) is an anomaly. Most stocks have been hit hard during the coronavirus-caused market sell-off. Shares of Inovio, on the other hand, have more than doubled so far in 2020 and at one point were up over 320% year to date. The bi… [+4185 chars]
Here's Why Inovio Pharmaceuticals Stock Crashed Today
An analyst downgrade caused gravity to kick in for the high-flying biotech stock.
What happened Shares of Inovio Pharmaceuticals(NASDAQ:INO) were crashing 23.5% lower as of 3:18 p.m. EDT on Friday after plunging as much as 30.5% earlier in the day. The biotech reported its fourth-quarter results after the market closed on Thursday, toppin… [+1509 chars]
Why Inovio Pharmaceuticals Is a Top Stock to Watch Amid the Coronavirus Pandemic
Here are three solid reasons to keep your eyes on this high-flying biotech stock.
COVID-19 is now officially a pandemic. Italy has basically locked down the entire country. The U.S. is suspending most travel from Europe. The NBA suspended the rest of its season. So did the NHL. Major League Baseball is delaying the start of its season. And… [+3639 chars]
Better Coronavirus Stock: Inovio vs. Regeneron
It's a COVID-19 version of David vs. Goliath. But does the giant win this battle?
There has been at least one group of stocks that has delivered tremendous returns so far in 2020. I'm referring to the stocks of companies that are developing drugs and vaccines targeting novel coronavirus disease COVID-19. Two of the leaders in these effort… [+4643 chars]
Better Coronavirus Stock: Gilead Sciences vs. Inovio Pharmaceuticals
One biotech is developing a promising antiviral treatment for COVID-19. The other is developing a promising vaccine. But one stock is clearly the better pick.
The world is eagerly awaiting some good news in the fight against the coronavirus and COVID-19, the disease that the virus causes. Several drugmakers are scrambling to become the first to provide that good news. Gilead Sciences(NASDAQ:GILD) and Inovio Pharma… [+5064 chars]
Inovio Gets $5 Million From Gates Foundation for a Device to Deliver Its Coronavirus Vaccine
The company hopes to have 1 million doses of its vaccine ready by the end of the year.
Inovio Pharmaceuticals(NASDAQ:INO) was just given a $5 million grant from the Bill & Melinda Gates Foundation to support the testing and scaling-up of production of a device designed to deliver the company's candidate coronavirus vaccine. Shares of Inovio… [+1563 chars]
Why Inovio Pharmaceuticals Stock Is Rising Today
The company may be in line for more COVID-19 grant money.
What happened Inovio Pharmaceuticals(NASDAQ:INO), a pre-revenue vaccine company, saw its shares rise by as much as 10% in pre-market trading Monday morning. The biotech's shares appear to be responding to the news that Facebook CEO Mark Zuckerberg and his wi… [+1591 chars]
Better Coronavirus Stock: Inovio Pharmaceuticals or GlaxoSmithKline?
Both of these companies are in the thick of the hunt to develop a coronavirus vaccine. Which stock is the better pick right now?
Drugmakers big and small are pulling out all the stops to develop treatments and vaccines for novel coronavirus disease COVID-19. Two that threw their hats into the ring early are Inovio Pharmaceuticals(NASDAQ:INO) and GlaxoSmithKline(NYSE:GSK). Inovio is on… [+4628 chars]
Better Coronavirus Stock: Inovio Pharmaceuticals vs. Novavax
These two biotechs are leaders in the race to develop a coronavirus vaccine. Which stock is the better pick for investors?
The race is on. Multiple drugmakers are rushing to test experimental antiviral drugs and vaccines that could treat or prevent the coronavirus and the disease that it causes, COVID-19. It's too early to know which companies will be successful, but a few of the… [+5370 chars]
Should Investors Buy or Sell Inovio Pharmaceuticals Right Now?
What's going on with this company and its coronavirus vaccine?
As COVID-19 outbreaks continue to spread around the world, biotech stocks working on possible treatments have become all the rage. Inovio Pharmaceuticals (NASDAQ:INO) has been one of the hottest biotech stocks on the market, with shares continuing to see dram… [+5958 chars]
Why Inovio Pharmaceuticals Stock Is Skyrocketing Today
Investors appear to be shrugging off a short-seller's tweet that caused a massive sell-off of the biotech stock yesterday.
What happened Shares of Inovio Pharmaceuticals(NASDAQ:INO) are skyrocketing today, up by 32.6% as of 11:17 a.m. EDT, after surging as much as 48.9% earlier in the session. The biotech didn't announce any news. However, investors appear to be jumping back int… [+1803 chars]
Why Is Everyone Talking About Inovio Pharmaceuticals Stock?
The biotech company has trounced the recent market thanks to its work developing a coronavirus vaccine, but you still might want to stay away.
Even after dipping into bear market territory last week, the stock market continues to fall due to fears surrounding the COVID-19 outbreak. On Monday, the S&P 500 fell by 12%, its biggest one-day drop since 1987. Meanwhile, the Dow Jones plunged by 13% th… [+4478 chars]
Better Coronavirus Stock: Inovio Pharmaceuticals vs. Vir Biotechnology
Both of these companies are fighting against the COVID-19 pandemic, but which one is the better buy?
COVID-19, the disease caused by the novel coronavirus, has been officially labeled a pandemic by the World Health Organization (WHO). In the U.S., there are now more than 1,200 confirmed cases and at least 29 deaths. Globally, over 100 countries have reported… [+5749 chars]
Will Inovio Pharmaceuticals Make a Fortune Off Its Coronavirus Vaccine?
Exactly how much money can Inovio make, and is it truly such a big deal?
Inovio Pharmaceuticals (NASDAQ:INO) is easily one of the most volatile stocks on the market, thanks in no small part to the company's COVID-19 vaccine, INO-4800. With the company promising to produce about 1 million vaccines by the end of the year for testing… [+5917 chars]
Inovio Pharmaceuticals, Inc. (INO) Q4 2019 Earnings Call Transcript
INO earnings call for the period ending December 31, 2019.
Image source: The Motley Fool. Inovio Pharmaceuticals, Inc. (NASDAQ:INO)Q4 2019 Earnings CallMar 12, 2020, 4:30 p.m. ET Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
INOVIO Pharmaceuticals, Inc. (INO) CEO J. Joseph Kim on Q4 2019 Results - Earnings Call Transcript
INOVIO Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2019 Earnings Conference Call March 12, 2020 4:30 PM ET Company Participants Ben Matone - Senior Director of Investor Relations J. Joseph Kim - President and CEO Kate Broderick - Senior Vice President of R&… [+45965 chars]
It’s Too Early to Tell If Inovio (INO) Is a COVID-19 Play, Says Analyst
The novel coronavirus is dominating headlines around the world right now. But in Maxim Group's latest report on Inovio Pharmaceuticals (INO), COVID-19 merits hardly a mention. Turns out, Maxim loves this stock, but not only because of Coronavirus.In Maxim's n…
The novel coronavirus is dominating headlines around the world right now. But in Maxim Group's latest report on Inovio Pharmaceuticals (INO), COVID-19 merits hardly a mention. Turns out, Maxim loves this stock, but not only because of Coronavirus. In Maxim's… [+3385 chars]
INOVIO Pharmaceuticals Reports 2019 Fourth Quarter and Year-End Financial Results
INOVIO Pharmaceuticals, Inc. (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases, today reported fi…
PLYMOUTH MEETING, Pa., March 12, 2020 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with H… [+25614 chars]